Comment on: [10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study]-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comment on: [10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study]

Published:2024-01 Issue: Volume:17 Page:
ISSN:1756-2848
Container-title:Therapeutic Advances in Gastroenterology
language:en
Short-container-title:Therap Adv Gastroenterol

Author:

Kamal Shahed¹^ORCID,Segal Jonathan P.²³^ORCID

Affiliation:

1. Department of Gastroenterology, Northern Health, 185 Cooper Street, Epping, Melbourne, VIC 3076, Australia

2. Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia

3. Department of Medicine, The University of Melbourne, Parkville, Melbourne, VIC, Australia

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/17562848241265761

Reference4 articles.

1. 10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study

2. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

3. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

4. Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP